BASEL, Switzerland, March 31, 2014 (GLOBE NEWSWIRE) -- Auris Medical announced today that results from its phase IIb clinical trial with AM-101 in the treatment of acute inner ear tinnitus have been published in the specialist journal Otology & Neurotology1. The trial demonstrated that AM-101 was well tolerated and safe and established proof of concept in the treatment of tinnitus arising from traumatic acoustic injury to the cochlea and otitis media. In particular the trial showed persistent, clinically relevant and statistically significant improvement in several patient-reported tinnitus measures.
Help employers find you! Check out all the jobs and post your resume.
